Mice Model Market

Mice Model Market (Product Type: Transgenic Mice Model, Hybrid/Congenic Mice Model, Knockout Mice Model, Outbred Mice Model, Inbred Mice Model, Transplantation Mice Model, and Others; Specialty and Service) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Mice Model Market Outlook 2028

  • The global mice model market was valued at US$ 1.5 Bn in 2020
  • It is estimated to expand at a CAGR of 6.2% from 2021 to 2028
  • The global mice model market is expected to reach the value of US$ 2.3 Bn by the end of 2028

Analysts’ Viewpoint on Mice Model Market Scenario

Since COVID-19 is linked with potential damage to organ systems, stakeholders in the healthcare industry are increasing research to develop vaccines and therapeutic agents against acute respiratory diseases. In many cases, animal testing has proven to be unreliable. Hence, the FDA (Food and Drug Administration) is predicted to implement the Modernization Act that would lift the compulsion of animal testing. Alternatives such as bio-printed organ models and human biology-based test methods hold promising potentials to replace ineffective mice models, thus inhibiting market growth. Due to these reasons, participants in the mice model market should unlock revenue opportunities in necessary healthcare applications such as for drug discovery and development. Animal models have and are anticipated to play an important role in the characterization of the pathophysiology of diseases and associated mechanisms of injury.

Need for Speedy Cancer Treatment Fueling Demand for Mice Models

Increased research & development (R&D) in gene technology, fueled by the need of accurate and speedy treatment in the changing medical industry, is augmenting the growth of the global mice model market. The identification of genomic differences to predict drug response or drug resistance by patients can offer scope to design a personalized therapy tailored to the specific characteristics of a particular cancer. The Mouse Avatar and Co-clinical Trial concepts have the capability to transform the drug development and healthcare process.

Demand for Vaccines Against Respiratory Diseases Grows Prominent amid COVID-19 Pandemic

The future possibilities for of the outbreak of COVID-19-like pandemics has brought stakeholders in the mice model market under great scrutiny by healthcare organizations. The high risk of morbidity and mortality associated with potential infectious outbreaks in the upcoming decade has heightened the need for vaccines and promising therapeutic agents to improve patient quality of life.

Since severe acute respiratory diseases can exacerbate into pneumonia, participants in the mice model market are expected to work closely with the World Health Organization (WHO) to increase research in vaccines and other therapeutic agents. Efforts are being made to prevent incidences of acute respiratory distress syndrome in patients.

Can Mice Model Testing Be Completely Eliminated from Healthcare Industry?

Rising concerns about animal use for research and teaching purposes has been raised in nearly every part of the world in the past few years. A large number of international social organizations, such as PETA (People for the Ethical Treatment of Animals), believe that animal studies teach nothing about the health of humans, as human reactions to medications and illnesses are completely different from the reactions of mice and other animals.

Due to these reasons, stakeholders in the mice model market should target their R&D capabilities toward necessary healthcare activities such as in modern drug discovery. Animal models play an instrumental role in the development of safe & effective treatments and cures for diseases and/or associated symptoms. Other applications include drug target identification & evaluation of novel therapeutic agents for toxicity/safety, pharmacokinetics, pharmacodynamics, and efficacy.

Studies for Identifying Gene-specific Functions Surging in Mice Model Market

Mice have been one of the most important research tools for basic and applied research in biomedical sciences, and this trend is anticipated to grow at a rapid rate. Besides providing precise correlation with human condition, the major advantage of mice models is the possibility of exploring precise gene-specific functions and various molecular events in living organisms. Combining mice models with advanced imaging technologies offer unique opportunities to understand the etiology and pathophysiology of human diseases.

Moreover, mice have been widely used in biomedical research to discover human diseases and to evaluate new drug candidates. Mouse research has led to major advances in treating a number of diseases and health conditions. For instance, experiments on mice models resulted in efficacious treatments for acute promyelocytic leukemia (APL) which was largely terminal.

Dynamic Functional Mice Models Hold Potentials to Treat Complex Lung Diseases

The global mice model market has witnessed the development of several mice models in the last decade. Advanced mice models not only increase applications, but also acceptability of these models for increasing the availability of treatment for complex diseases.

Researchers are creating dynamic functional mice models for lung injury repair. This model would help in understanding some of the most complex aspects of lung diseases, and would be used for testing new therapies. The development of such models is likely to boost growth for the mice model market growth and increase funding for biomedical research. Furthermore, large pharmaceutical companies are focusing on entering into partnerships with institutes or companies specializing in the development of these models, providing a new source of funding and revenue generation.

Mice Model Market: Overview

  • According to Transparency Market Research’s latest report on the global mice model market for the historical period 2017–2019 and forecast period 2021–2028, increase in demand for mice models in personalized medicine due to development of personalized in vivo analysis mice models is projected to boost the growth of the global market during the forecast period

Rise in Investment in Biomedical Research: Key Driver

  • Investment in biomedical research is considered one of the most important indicators of a country’s research landscape. In the past 10 years, biomedical research expenditure has increased manifold globally. Investment in biomedical research is rising in most parts of the world. However, a few developed countries such as the U.S. and the U.K. have shown a cut down in research expenditure. A significant percent of these investments is utilized in basic research based on animal models.
  • Over 60% of the National Institute of Health (NIH) extramural funding involves animal-related research, of which majority is allotted for mice-related studies. Increase in funding for biomedical research is expected to boost the growth of the global mice model market over the next few years.

Surge in Number of Advanced Mice Models Offering Applicability and Acceptability: Major Driver

  • The global mice model market has witnessed development of several mice models in the past few years. Advanced mice models not only increase the applications, but also acceptability of these models for complex diseases.
  • Researchers at the Children's Hospital Los Angeles and The Saban Research Institute of CHLA created a dynamic functional mouse model for lung injury repair. This model would help in understanding some of the most complex aspects of lung disease and would be used for testing new therapies. Development of such models is likely to boost market growth and increase funding for biomedical research. Moreover, large pharmaceutical companies focus on entering into alliances with institutes or companies specializing in the development of these models, providing a new source of funding and revenue generation.

Rise in Concerns about Animal Use to Restrain Global Market

  • Concerns about animal use for research and teaching purposes have been raised in nearly every part of the world in the past few years. Large number of international social organizations, such as PETA, believe that animal studies teach nothing about the health of humans because human reactions to illnesses and medications are completely different from the reactions of other animals.

Mice Model Market: Competition Landscape

  • This report profiles major players in the global mice model market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global mice model market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global mice model market are
    • Charles River Laboratories
    • Crescendo Biologics Limited
    • Deltagen, Inc.
    • GenOway S.A.
    • Harlan Laboratories, Inc.
    • ImmunoGenes AG
    • Taconic Biosciences, Inc.
    • Lexicon Pharmaceuticals
    • SAGE Labs
    • The Jackson Laboratory
    • Taconic Biosciences, Inc.
    • TransGenic, Inc., among others

Mice Model Market: Key Developments

  • Key players in the global mice model market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global mice model market. A few expansion strategies adopted by players operating in the global mice model market are:
    • In January 2020, Taconic Biosciences announced the expansion of its premier immuno-oncology product portfolio with the inclusion of the new B2m-NOG mouse model
  • The report on the global mice model market discusses individual strategies, followed by company profiles of manufacturers of stem cell products. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global mice model market.

Mice Model Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 1.5 Bn

Market Forecast Value in 2028

US$ 2.3 Bn

Growth Rate (CAGR)

6.2%

Forecast Period

2021–2028

Quantitative Units

US$ Bn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Type
    • Transgenic Mice Model
    • Hybrid / Congenic Mice Model
    • Knockout Mice Model
    • Carcinogen-induced & Spontaneous Mice Model
    • Outbred Mice Model
    • Inbred Mice Model
    • Transplantation Mice Model
    • Conditioned / Surgically Modified Mice Model
  • Specialty
    • Immunology
    • Central Nervous System (CNS)
    • Oncology
    • Cardiovascular
    • Diabetes
    • Metabolism & Regulation
  • Service
    • Breeding & Rederivation Services
    • Cryopreservation & Cryorecovery Services
    • Quarantine Services
    • Genetic Testing Services
    • Model In-licensing Services
    • In Vivo & In Vitro Pharmacology Services
    • Genetically Engineered Model Services
    • Other Services (Surgical and Line Rescue)

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Charles River Laboratories
  • Crescendo Biologics Limited
  • Deltagen, Inc.
  • GenOway S.A.
  • Harlan Laboratories, Inc.
  • ImmunoGenes AG
  • Taconic Biosciences, Inc.
  • Lexicon Pharmaceuticals
  • SAGE Labs
  • The Jackson Laboratory
  • Taconic Biosciences, Inc.
  • TransGenic, Inc.
  • Others

Customization Scope

Available upon request

Pricing

Available upon request

Mice Model Market - Segmentation

Product Type
  • Transgenic Mice Model
  • Hybrid / Congenic Mice Model
  • Knockout Mice Model
  • Carcinogen/induced & Spontaneous Mice Model
  • Outbred Mice Model
  • Inbred Mice Model
  • Transplantation Mice Model
  • Conditioned / Surgically Modified Mice Model
Specialty
  • Immunology
  • Central Nervous System (CNS)
  • Oncology
  • Cardiovascular
  • Diabetes
  • Metabolism & Regulation
Service
  • Breeding & Rederivation Services
  • Cryopreservation & Cryorecovery Services
  • Quarantine Services
  • Genetic Testing Services
  • Model In-licensing Services
  • In Vivo & In Vitro Pharmacology Services
  • Genetically Engineered Model Services
  • Other Services (Surgical and Line Rescue)
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of mice model market?

The global mice model market is projected to reach a value of US$ 2.3 Bn by the end of 2028

What is the anticipated CAGR of the mice model market in the forecast period?

Mice model market is anticipated to grow at a CAGR of 6.2% during the forecast period

Which region is expected to project the highest market share in the mice model market?

North America accounted for a major share of the global mice model market

What are the key driving factors for the growth of mice model market?

Mice model market is driven by increase in demand for mice models in personalized medicine due to development of personalized in vivo analysis mice models

Who are the key players in the global mice model market?

Key players in the global mice model market include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Mice Model Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Type Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Mice Model Market Analysis and Forecast, 2017–2028

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Industry Developments

        5.2. Overview of Mice Model Market

        5.3. Technological Advancements

        5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

    6. Global Mice Model Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Type, 2017–2028

            6.3.1. Transgenic Mice Model

            6.3.2. Hybrid/Congenic Mice Model

            6.3.3. Knockout Mice Model

            6.3.4. Carcinogen-induced & Spontaneous Mice Model

            6.3.5. Outbred Mice Model

            6.3.6. Inbred Mice Model

            6.3.7. Transplantation Mice Model

            6.3.8. Conditioned/Surgically Modified Mice Model

        6.4. Market Attractiveness Analysis, by Type

    7. Global Mice Model Market Analysis and Forecast, by Specialty

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Specialty, 2017–2028

            7.3.1. Immunology

            7.3.2. Central Nervous System (CNS)

            7.3.3. Oncology

            7.3.4. Cardiovascular

            7.3.5. Diabetes

            7.3.6. Metabolism & Regulation

        7.4. Market Attractiveness Analysis, by Specialty

    8. Global Mice Model Market Analysis and Forecast, by Services

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Services, 2017–2028

            8.3.1. Breeding & Rederivation Services

            8.3.2. Cryopreservation & Cryorecovery Services

            8.3.3. Quarantine Services

            8.3.4. Genetic Testing Services

            8.3.5. Model In-licensing Services

            8.3.6. In Vivo & In Vitro Pharmacology Services

            8.3.7. Genetically Engineered Model Services

            8.3.8. Other Services (surgical and line rescue)

        8.4. Market Attractiveness Analysis, by Services

    9. Global Mice Model Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Country/Region

    10. North America Mice Model Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Type, 2017–2028

            10.2.1. Transgenic Mice Model

            10.2.2. Hybrid/Congenic Mice Model

            10.2.3. Knockout Mice Model

            10.2.4. Carcinogen-induced & Spontaneous Mice Model

            10.2.5. Outbred Mice Model

            10.2.6. Inbred Mice Model

            10.2.7. Transplantation Mice Model

            10.2.8. Conditioned/Surgically Modified Mice Model

        10.3. Market Value Forecast, by Specialty, 2017–2028

            10.3.1. Immunology

            10.3.2. Central Nervous System (CNS)

            10.3.3. Oncology

            10.3.4. Cardiovascular

            10.3.5. Diabetes

            10.3.6. Metabolism & Regulation

        10.4. Market Value Forecast, by Services, 2017–2028

            10.4.1. Breeding & Rederivation Services

            10.4.2. Cryopreservation & Cryorecovery Services

            10.4.3. Quarantine Services

            10.4.4. Genetic Testing Services

            10.4.5. Model In-licensing Services

            10.4.6. In Vivo & In Vitro Pharmacology Services

            10.4.7. Genetically Engineered Model Services

            10.4.8. Other Services (surgical and line rescue)

        10.5. Market Value Forecast, by Country, 2017–2028

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Type

            10.6.2. By Specialty

            10.6.3. By Services

            10.6.4. By Country

    11. Europe Mice Model Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Type, 2017–2028

            11.2.1. Transgenic Mice Model

            11.2.2. Hybrid/Congenic Mice Model

            11.2.3. Knockout Mice Model

            11.2.4. Carcinogen-induced & Spontaneous Mice Model

            11.2.5. Outbred Mice Model

            11.2.6. Inbred Mice Model

            11.2.7. Transplantation Mice Model

            11.2.8. Conditioned/Surgically Modified Mice Model

        11.3. Market Value Forecast, by Specialty, 2017–2028

            11.3.1. Immunology

            11.3.2. Central Nervous System (CNS)

            11.3.3. Oncology

            11.3.4. Cardiovascular

            11.3.5. Diabetes

            11.3.6. Metabolism & Regulation

        11.4. Market Value Forecast, by Services, 2017–2028

            11.4.1. Breeding & Rederivation Services

            11.4.2. Cryopreservation & Cryorecovery Services

            11.4.3. Quarantine Services

            11.4.4. Genetic Testing Services

            11.4.5. Model In-licensing Services

            11.4.6. In Vivo & In Vitro Pharmacology Services

            11.4.7. Genetically Engineered Model Services

            11.4.8. Other Services (surgical and line rescue)

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2028

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Type

            11.6.2. By Specialty

            11.6.3. By Services

            11.6.4. By Country/Sub-region

    12. Asia Pacific Mice Model Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Type, 2017–2028

            12.2.1. Transgenic Mice Model

            12.2.2. Hybrid/Congenic Mice Model

            12.2.3. Knockout Mice Model

            12.2.4. Carcinogen-induced & Spontaneous Mice Model

            12.2.5. Outbred Mice Model

            12.2.6. Inbred Mice Model

            12.2.7. Transplantation Mice Model

            12.2.8. Conditioned/Surgically Modified Mice Model

        12.3. Market Value Forecast, by Specialty, 2017–2028

            12.3.1. Immunology

            12.3.2. Central Nervous System (CNS)

            12.3.3. Oncology

            12.3.4. Cardiovascular

            12.3.5. Diabetes

            12.3.6. Metabolism & Regulation

        12.4. Market Value Forecast, by Services, 2017–2028

            12.4.1. Breeding & Rederivation Services

            12.4.2. Cryopreservation & Cryorecovery Services

            12.4.3. Quarantine Services

            12.4.4. Genetic Testing Services

            12.4.5. Model In-licensing Services

            12.4.6. In Vivo & In Vitro Pharmacology Services

            12.4.7. Genetically Engineered Model Services

            12.4.8. Other Services (surgical and line rescue)

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2028

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Type

            12.6.2. By Specialty

            12.6.3. By Services

            12.6.4. By Country/Sub-region

    13. Latin America Mice Model Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Type , 2017–2028

            13.2.1. Transgenic Mice Model

            13.2.2. Hybrid/Congenic Mice Model

            13.2.3. Knockout Mice Model

            13.2.4. Carcinogen-induced & Spontaneous Mice Model

            13.2.5. Outbred Mice Model

            13.2.6. Inbred Mice Model

            13.2.7. Transplantation Mice Model

            13.2.8. Conditioned/Surgically Modified Mice Model

        13.3. Market Value Forecast, by Specialty, 2017–2028

            13.3.1. Immunology

            13.3.2. Central Nervous System (CNS)

            13.3.3. Oncology

            13.3.4. Cardiovascular

            13.3.5. Diabetes

            13.3.6. Metabolism & Regulation

        13.4. Market Value Forecast, by Services, 2017–2028

            13.4.1. Breeding & Rederivation Services

            13.4.2. Cryopreservation & Cryorecovery Services

            13.4.3. Quarantine Services

            13.4.4. Genetic Testing Services

            13.4.5. Model In-licensing Services

            13.4.6. In Vivo & In Vitro Pharmacology Services

            13.4.7. Genetically Engineered Model Services

            13.4.8. Other Services (surgical and line rescue)

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2028

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Type

            13.6.2. By Specialty

            13.6.3. By Services

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Mice Model Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Type, 2017–2028

            14.2.1. Transgenic Mice Model

            14.2.2. Hybrid/Congenic Mice Model

            14.2.3. Knockout Mice Model

            14.2.4. Carcinogen-induced & Spontaneous Mice Model

            14.2.5. Outbred Mice Model

            14.2.6. Inbred Mice Model

            14.2.7. Transplantation Mice Model

            14.2.8. Conditioned/Surgically Modified Mice Model

        14.3. Market Value Forecast, by Specialty, 2017–2028

            14.3.1. Immunology

            14.3.2. Central Nervous System (CNS)

            14.3.3. Oncology

            14.3.4. Cardiovascular

            14.3.5. Diabetes

            14.3.6. Metabolism & Regulation

        14.4. Market Value Forecast, by Services, 2017–2028

            14.4.1. Breeding & Rederivation Services

            14.4.2. Cryopreservation & Cryorecovery Services

            14.4.3. Quarantine Services

            14.4.4. Genetic Testing Services

            14.4.5. Model In-licensing Services

            14.4.6. In Vivo & In Vitro Pharmacology Services

            14.4.7. Genetically Engineered Model Services

            14.4.8. Other Services (surgical and line rescue)

        14.5. Market Value Forecast, by Country, 2017–2028

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Type

            14.6.2. By Specialty

            14.6.3. By Services

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Company Profiles

            15.2.1. Charles River Laboratories International, Inc.

                15.2.1.1. Company Overview

                15.2.1.2. Financial Overview

                15.2.1.3. Product Portfolio

                15.2.1.4. Business Strategies

                15.2.1.5. Recent Developments

            15.2.2. Crescendo Biologics Limited

                15.2.2.1. Company Overview

                15.2.2.2. Financial Overview

                15.2.2.3. Product Portfolio

                15.2.2.4. Business Strategies

                15.2.2.5. Recent Developments

            15.2.3. Deltagen, Inc.

                15.2.3.1. Company Overview

                15.2.3.2. Financial Overview

                15.2.3.3. Product Portfolio

                15.2.3.4. Business Strategies

                15.2.3.5. Recent Developments

            15.2.4. genOway S.A.

                15.2.4.1. Company Overview

                15.2.4.2. Financial Overview

                15.2.4.3. Product Portfolio

                15.2.4.4. Business Strategies

                15.2.4.5. Recent Developments

            15.2.5. Harbour Antibodies BV

                15.2.5.1. Company Overview

                15.2.5.2. Financial Overview

                15.2.5.3. Product Portfolio

                15.2.5.4. Business Strategies

                15.2.5.5. Recent Developments

            15.2.6. Harlan Laboratories, Inc.

                15.2.6.1. Company Overview

                15.2.6.2. Financial Overview

                15.2.6.3. Product Portfolio

                15.2.6.4. Business Strategies

                15.2.6.5. Recent Developments

            15.2.7. ImmunoGenes AG

                15.2.7.1. Company Overview

                15.2.7.2. Financial Overview

                15.2.7.3. Product Portfolio

                15.2.7.4. Business Strategies

                15.2.7.5. Recent Developments

            15.2.8. The Jackson Laboratory

                15.2.8.1. Company Overview

                15.2.8.2. Financial Overview

                15.2.8.3. Product Portfolio

                15.2.8.4. Business Strategies

                15.2.8.5. Recent Developments

            15.2.9. Taconic Biosciences, Inc.

                15.2.9.1. Company Overview

                15.2.9.2. Financial Overview

                15.2.9.3. Product Portfolio

                15.2.9.4. Business Strategies

                15.2.9.5. Recent Developments

            15.2.10. TransGenic, Inc.

                15.2.10.1. Company Overview

                15.2.10.2. Financial Overview

                15.2.10.3. Product Portfolio

                15.2.10.4. Business Strategies

                15.2.10.5. Recent Developments

    List of Tables

    Table 01: Global Mice Model Market Value (US$ Mn) Forecast, by Type, 2017‒2031

    Table 02: Global Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017‒2031

    Table 03: Global Mice Model Market Value (US$ Mn) Forecast, by Services, 2017‒2031

    Table 04: Global Mice Model Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Mice Model Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Mice Model Market Value (US$ Mn) Forecast, by Type, 2017‒2031

    Table 07: North America Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017‒2031

    Table 08: North America Mice Model Market Value (US$ Mn) Forecast, by Services, 2017‒2031

    Table 09: Europe Mice Model Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Mice Model Market Value (US$ Mn) Forecast, by Type, 2017‒2031

    Table 11: Europe Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017‒2031

    Table 12: Europe Mice Model Market Value (US$ Mn) Forecast, by Services, 2017‒2031

    Table 13: Asia Pacific Mice Model Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Mice Model Market Value (US$ Mn) Forecast, by Type, 2017‒2031

    Table 15: Europe Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017‒2031

    Table 16: Europe Mice Model Market Value (US$ Mn) Forecast, by Services, 2017‒2031

    Table 17: Latin America Mice Model Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Mice Model Market Value (US$ Mn) Forecast, by Type, 2017‒2031

    Table 19: Latin America Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017‒2031

    Table 20: Latin America Mice Model Market Value (US$ Mn) Forecast, by Services, 2017‒2031

    Table 21: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, by Type, 2017‒2031

    Table 23: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, by Specialty, 2017‒2031

    Table 24: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, by Services, 2017‒2031

    List of Figures

    Figure 01: Global Mice Model Market Value (US$ Mn) Forecast, 2017–2028

    Figure 02: Global Mice Model Market Value Share, by Type, 2020

    Figure 03: Global Mice Model Market Value Share, by Specialty, 2020

    Figure 04: Global Mice Model Market Value Share, by Services, 2020

    Figure 05: Global Mice Model Market Value Share, by Region, 2020

    Figure 06: Global Mice Model Market, by Type, 2017 and 2028

    Figure 07: Global Mice Model Market Attractiveness Analysis, by Type, 2020–2028

    Figure 08: Global Mice Model Market (US$ Mn), by Transgenic Mice Model, 2017–2028

    Figure 09: Global Mice Model Market (US$ Mn), by Hybrid/Congenic Mice Model, 2017–2028

    Figure 10: Global Mice Model Market (US$ Mn), by Knockout Mice Model, 2017–2028

    Figure 11: Global Mice Model Market (US$ Mn), by Carcinogen-induced & Spontaneous Mice Model, 2017–2028

    Figure 12: Global Mice Model Market (US$ Mn), by Outbred Mice Model, 2017–2028

    Figure 13: Global Mice Model Market (US$ Mn), by Inbred Mice Model, 2017–2028

    Figure 14: Global Mice Model Market (US$ Mn), by Transplantation Mice Model, 2017–2028

    Figure 15: Global Mice Model Market (US$ Mn), by Conditioned/Surgically Modified Mice Model, 2017–2028

    Figure 16: Global Mice Model Market, by Specialty, 2017 and 2028

    Figure 17: Global Mice Model Market Attractiveness Analysis, by Specialty, 2020–2028

    Figure 18: Global Mice Model Market (US$ Mn), by Immunology, 2017–2028

    Figure 19: Global Mice Model Market (US$ Mn), by Central Nervous System (CNS), 2017–2028

    Figure 20: Global Mice Model Market (US$ Mn), by Oncology, 2017–2028

    Figure 21: Global Mice Model Market (US$ Mn), by Cardiovascular, 2017–2028

    Figure 22: Global Mice Model Market (US$ Mn), by Diabetes, 2017–2028

    Figure 23: Global Mice Model Market Attractiveness Analysis, by Services, 2020–2028

    Figure 24: Global Mice Model Market (US$ Mn), by Cryopreservation & Cryorecovery Services, 2017–2028

    Figure 25: Global Mice Model Market (US$ Mn), by Quarantine Services, 2017–2028

    Figure 26: Global Mice Model Market (US$ Mn), by Genetic Testing Services, 2017–2028

    Figure 27: Global Mice Model Market (US$ Mn), by Model In-licensing Services, 2017–2028

    Figure 28: Global Mice Model Market (US$ Mn), by In Vivo & In Vitro Pharmacology Services, 2017–2028

    Figure 29: Global Mice Model Market (US$ Mn), by Genetically Engineered Model Services, 2017–2028

    Figure 30: Global Mice Model Market (US$ Mn), Other services (surgical and line rescue), 2017–2028

    Figure 31: North America Mice Model Market Value (US$ Mn) Forecast, 2017–2028

    Figure 32: North America Mice Model Market Value Share Analysis, by Country, 2017 and 2028

    Figure 33: North America Mice Model Market, by Type, 2017 and 2028

    Figure 34: North America Mice Model Market Attractiveness Analysis, by Type, 2020–2028

    Figure 35: North America Mice Model Market, by Specialty, 2017 and 2028

    Figure 36: North America Mice Model Market Attractiveness Analysis, by Specialty, 2020–2028

    Figure 37: North America Mice Model Market, by Services, 2017 and 2028

    Figure 38: North America Mice Model Market Attractiveness Analysis, by Services, 2020–2028

    Figure 39: Europe Mice Model Market Value (US$ Mn) Forecast, 2017–2028

    Figure 40: Europe Mice Model Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

    Figure 41: Europe Mice Model Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

    Figure 42: Europe Mice Model Market, by Type, 2017 and 2028

    Figure 43: Europe Mice Model Market Attractiveness Analysis, by Type, 2020–2028

    Figure 44: Europe Mice Model Market, by Specialty, 2017 and 2028

    Figure 45: Europe Mice Model Market Attractiveness Analysis, by Specialty, 2020–2028

    Figure 46: Europe Mice Model Market, by Services, 2017 and 2028

    Figure 47: Europe Mice Model Market Attractiveness Analysis, by Services, 2020–2028

    Figure 48: Asia Pacific Mice Model Market Value (US$ Mn) Forecast, 2017–2028

    Figure 49: Asia Pacific Mice Model Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

    Figure 50: Asia Pacific Mice Model Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

    Figure 51: Asia Pacific Mice Model Market, by Type, 2017 and 2028

    Figure 52: Asia Pacific Mice Model Market Attractiveness Analysis, by Type, 2020–2028

    Figure 53: Asia Pacific Mice Model Market, by Specialty, 2017 and 2028

    Figure 54: Asia Pacific Mice Model Market Attractiveness Analysis, by Specialty, 2020–2028

    Figure 55: Asia Pacific Mice Model Market, by Services, 2017 and 2028

    Figure 56: Asia Pacific Mice Model Market Attractiveness Analysis, by Services, 2020–2028

    Figure 57: Latin America Mice Model Market Value (US$ Mn) Forecast, 2017–2028

    Figure 58: Latin America Mice Model Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

    Figure 59: Latin America Mice Model Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

    Figure 60: Latin America Mice Model Market, by Type, 2017 and 2028

    Figure 61: Latin America Mice Model Market Attractiveness Analysis, by Type, 2020–2028

    Figure 62: Latin America Mice Model Market, by Specialty, 2017 and 2028

    Figure 63: Latin America Mice Model Market Attractiveness Analysis, by Specialty, 2020–2028

    Figure 64: Latin America Mice Model Market, by Services, 2017 and 2028

    Figure 65: Latin America Mice Model Market Attractiveness Analysis, by Services, 2020–2028

    Figure 66: Middle East & Africa Mice Model Market Value (US$ Mn) Forecast, 2017–2028

    Figure 67: Middle East & Africa Mice Model Market Value Share Analysis, by Country/Sub-region, 2017 and 2028

    Figure 68: Middle East & Africa Mice Model Market Attractiveness Analysis, by Country/Sub-region, 2020–2028

    Figure 69: Middle East & Africa Mice Model Market, by Type, 2017 and 2028

    Figure 70: Middle East & Africa Mice Model Market Attractiveness Analysis, by Type, 2020–2028

    Figure 71: Middle East & Africa Mice Model Market, by Specialty, 2017 and 2028

    Figure 72: Middle East & Africa Mice Model Market Attractiveness Analysis, by Specialty, 2020–2028

    Figure 73: Middle East & Africa Mice Model Market, by Services, 2017 and 2028

    Figure 74: Middle East & Africa Mice Model Market Attractiveness Analysis, by Services, 2020–2028

Copyright © Transparency Market Research, Inc. All Rights reserved